Adenosinergic-dopaminergic signaling in mood disorders: a mini-review (2020)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; GLASER, TALITA - IQ
- Unidade: IQ
- DOI: 10.1089/caff.2020.0009
- Subjects: DEPRESSÃO; TRANSTORNO BIPOLAR; ADENOSINA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Caffeine and Adenosine Research
- ISSN: 2573-3397
- Volume/Número/Paginação/Ano: v. 10, n. 3, p. 94-103, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GONÇALVES, Maria Carolina Bittencourt et al. Adenosinergic-dopaminergic signaling in mood disorders: a mini-review. Journal of Caffeine and Adenosine Research, v. 10, n. 3, p. 94-103, 2020Tradução . . Disponível em: https://doi.org/10.1089/caff.2020.0009. Acesso em: 26 dez. 2025. -
APA
Gonçalves, M. C. B., Glaser, T., Oliveira, S. L. B. de, & Ulrich, H. (2020). Adenosinergic-dopaminergic signaling in mood disorders: a mini-review. Journal of Caffeine and Adenosine Research, 10( 3), 94-103. doi:10.1089/caff.2020.0009 -
NLM
Gonçalves MCB, Glaser T, Oliveira SLB de, Ulrich H. Adenosinergic-dopaminergic signaling in mood disorders: a mini-review [Internet]. Journal of Caffeine and Adenosine Research. 2020 ; 10( 3): 94-103.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1089/caff.2020.0009 -
Vancouver
Gonçalves MCB, Glaser T, Oliveira SLB de, Ulrich H. Adenosinergic-dopaminergic signaling in mood disorders: a mini-review [Internet]. Journal of Caffeine and Adenosine Research. 2020 ; 10( 3): 94-103.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1089/caff.2020.0009 - Purinergic receptors in neurogenic processes
- Purinergic signaling: an overview
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Purinergic signaling in liver disease: calcium signaling and induction of inflammation
- Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
- Purinergic signaling in brain physiology
- Therapeutic effects of cannabinoids and their applications in COVID-19 treatment
- P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway
- Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
- Organoids as a novel tool in modelling infectious diseases
Informações sobre o DOI: 10.1089/caff.2020.0009 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
